The Patent Finder

Amorfix Life Sciences Ltd.

Also on record
Records under this name other than patents Amorfix Life Sciences Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Amorfix Life Sciences Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,513,387Methods and Compositions for Detecting Amyotrophic Lateral Sclerosis
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,977,314Methods and Compositions to Treat and Detect MISFOLDED-SOD1 Mediated Diseases
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,053,510FasR ANTIBODIES AND METHODS OF USE
Formerly held
Lapsed on the fee record
Ended Aug 21, 2026 · High confidence
Lapsed on the fee recordEnded Aug 21, 2026High confidence
US 8,709,422Methods and Compositions to Treat and Detect Misfolded-SOD1 Mediated Diseases
Formerly held
Lapsed on the fee record
Ended Apr 29, 2026 · Low confidence
Lapsed on the fee recordEnded Apr 29, 2026Low confidence
US 7,887,803Methods and compositions to treat misfolded-SOD1 mediated diseases
Formerly held
Term ended
Term ended Aug 12, 2025 · USPTO record
Term endedTerm ended Aug 12, 2025USPTO record
US 9,637,552Methods and Compositions to Treat and Detect Misfolded-SOD1 Mediated DIseases
Formerly held
Lapsed on the fee record
Ended May 2, 2025 · Low confidence
Lapsed on the fee recordEnded May 2, 2025Low confidence
US 9,523,697Detection of pathogenic abeta using an epitope protection assay
Formerly held
Lapsed on the fee record
Ended Dec 20, 2024 · USPTO record
Lapsed on the fee recordEnded Dec 20, 2024USPTO record
US 7,439,324ALS-specific peptide composition
Formerly held
Term ended
Term ended Dec 11, 2024 · USPTO record
Term endedTerm ended Dec 11, 2024USPTO record
US 9,625,476Methods of diagnosing ALS
Formerly held
Term ended
Term ended Aug 20, 2024 · USPTO record
Term endedTerm ended Aug 20, 2024USPTO record
US 9,296,819Antibodies and Conjugates That Target Misfolded Prion Protein
Formerly held
Lapsed on the fee record
Ended Mar 29, 2024 · High confidence
Lapsed on the fee recordEnded Mar 29, 2024High confidence
10 of 15 patents shown.
Pro members see all 15.
Pro members: see all 15 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited